Jennifer Friel Goldstein, BSE/MB/MBA, is the Head of Business Development, Technology and Healthcare for Silicon Valley Bank.
Jennifer is responsible for Business Development, Venture Capital Relationship Management, and Corporate Relationship Management across all sectors for the bank. Jennifer and her teams help innovators and the partners they depend upon drive new business and enact change within the innovation ecosystem. These teams also focus on transformative partnerships to accelerate growth for our clients, our stakeholders, and across SVB’s diverse businesses.
Jennifer has held a variety of roles during her tenure at Silicon Valley Bank including running the Biotechnology and Diagnostics practice, heading up West Coast Healthcare, starting our Healthcare Accelerator practice for pre-Series A companies, and managing our Strategic Advisory Services practice. Additionally, Jennifer was directly involved with the company’s acquisition of Leerink Partners in January 2019.
Jennifer joined SVB after a successful tenure at Pfizer, where she served as a director on Pfizer’s Venture Capital team. While a consultant at Bain & Company in London, Jennifer focused on private equity deals across Europe. She has also had diverse operational and research experience at companies such as Chiron, Genelabs, and Genencor.
Jennifer brings 20 years of investing, banking, business development, portfolio management, and strategy experience as well as a biotechnology background to the team. She graduated magna cum laude with a BSE in Bioengineering and a Master’s of Biotechnology from the University of Pennsylvania. Jennifer was also named a Joseph Wharton Fellow while completing her MBA at the Wharton School.
A Bay Area native, Jennifer also enjoys serving on the advisory board of SpringBoard Enterprises, holding an independent board seat at Alexandria Real Estate Equities, serving on the board of the Leukemia and Lymphoma Society in Silicon Valley, and spending time with her husband and their twin children.